Access Bio researches, develops and manufactures in vitro diagnostic tests, bio-sensors and molecular diagnostic products.
Business Model:
Revenue: $36.4M
Employees: 51-200
Address: 65 Clyde Rd
City: Somerset
State: NJ
Zip: 08873
Country: US
Access Bio researches, develops and manufactures in vitro diagnostic tests, bio-sensors and molecular diagnostic products.
Contact Phone:
+17328734040
Contact Email:
Listed Exchange:
Korea Exchange
IPO Date:
6/7/2013
Ticker Symbol:
950130
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2016 | Convertible Note | $8M |
The Global Health Investment Fund |
4/2016 | Post-IPO Debt | 1 | $8M |
Global Health Investment Fund (GHIF) Global Health Investment Fund (GHIF) |
5/2011 | Venture Round | $12M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|